How a hospital buys a new device
Through a chain of approvals, any of which can stop the sale.
- A clinical champion, such as a physician, nurse leader or department head, submits a new product request, and without that sponsor many hospitals will not start a review.
- A value analysis committee weighs the evidence, the total cost and what the device replaces.
- Supply chain checks whether the product sits on a GPO or system contract, and negotiates if it does not.
- A purchase order follows.
What an IDN is, and how system buying changes the sale
An integrated delivery network (IDN) is a group of hospitals, physician practices and other care sites under common ownership or management that coordinates care and business functions, including purchasing, across the network. The American Hospital Association's Fast Facts on U.S. Hospitals, 2026 counts 5,121 US community hospitals, 3,567 of them in a system, from its 2024 annual survey.
Many systems run value analysis and sourcing centrally and standardize on a few suppliers in a category, so a win can open every hospital and a loss can close them all, and a yes at one site can need a second yes at the system. A common way in is an evaluation at one hospital with agreed success measures, then a case to extend it.
What a GPO contract is, and when it matters
A group purchasing organization (GPO) negotiates contracts with manufacturers, distributors and other suppliers on behalf of its members, usually hospitals and other providers, using their combined buying volume. A GPO contract sets the prices and terms members can buy under. It does not place an order by itself.
In a 2012 report, the US Government Accountability Office reports that vendors pay GPOs a percentage of what members buy through the contract, and that these payments are the GPOs' main source of operating revenue.
For a new or differentiated device, value analysis often comes first, and a GPO contract follows once enough members want the product. IDNs commonly belong to a GPO, so a device company usually meets both.
What a value analysis committee wants to see
The committee, usually clinicians, supply chain and finance, decides on evidence and total value, and typically asks for the following.
- Clinical evidence against what the hospital uses.
- Regulatory status, meaning the FDA marketing authorization, for example a 510(k) clearance, and the indications it covers.
- Total cost, including procedure time, length of stay, disposables, service and staff time.
- Reimbursement, what the device replaces, and the training and service behind it.
Who to reach first
Device companies usually start with the clinicians who feel the problem, such as department chairs, physicians, nurse managers and service line leaders. Value analysis and supply chain come in once there is real interest. Champions at several hospitals raising the same need make a far stronger case than one.
How long the cycle runs
Months rather than weeks, and longer for capital equipment and system-wide decisions. Cycles shorten with a champion who has a documented problem, a committee-ready request, a clear contract route and a defined evaluation with an end date.
Where outbound fits
Outbound starts the conversations the hospital process needs, at more hospitals than a field team can visit, while the reps own the relationship and close. After a contract award it tells each member facility and books the local evaluation.
Outreach to clinicians runs inside the device company's own compliance program, from its approved claims and business contact data, never patient data. This guide describes how hospitals buy. It is not legal advice.
Enquirer builds and runs this kind of outbound unit for device companies that sell into hospitals and health systems, then hands it to the client's team.